caselaw.findlaw.com/us-3rd-circuit/1313639.html

ASTRAZENECA PHARMACEUTICALS LP. ... Alvin EMORY, Appellant v. ... of the Americans with Disabilities Act (“ADA”), 42 U.S.C. § 12101 et seq. Moving for summary judgment, AstraZeneca urged that Emory's substantive ... In all, Emory bid unsuccessfully for approximately ten internal promotions over a 12-year period.

caselaw.findlaw.com/us-1st-circuit/1858969.html

Case opinion for US 1st Circuit TAYMARI DELGADO ECHEVARRÍA v. ASTRAZENECA PHARMACEUTICAL LP ASTRAZENECA LP. ... As in all other summary-judgment cases, we view the facts (and all reasonable inferences that can be ...

caselaw.findlaw.com/us-3rd-circuit/1681038.html

Case opinion for US 3rd Circuit UNITED STATES SCHUMANN v. ... ASTRAZENECA PHARMACEUTICALS L.P.; Astrazeneca LP; Bristol–Myers Squibb ... 31 U.S.C. § 3729 et seq., and corresponding state laws, appeals the District Court's .... At all relevant times, BMS participated in Medicaid's Drug Rebate Program with ...

www.law360.com/cases/59e6216bb9a1b52a7e000001

Parties, docket activity and news coverage of federal case ATCHLEY et al v. ASTRAZENECA UK ... Defendant. ASTRAZENECA PHARMACEUTICALS LP ...

law.justia.com/cases/federal/appellate-courts/ca9/17-55461/17-55461-2018-06-28.html

Jun 28, 2018 ... CINDI BEKINS V. ASTRAZENECA PHARMACEUTICALS LP, No. 17-55461 (9th Cir. 2018) case opinion from the US Court of Appeals for the ...

ecf.ksd.uscourts.gov/cgi-bin/Opinions.pl?year=2017

Sawyers v. Mo-Kan Teamsters Pension Plan et al, Doc No. ... National Railroad Passenger Corp. et al v. ...... AstraZeneca Pharmaceuticals LP et al, Doc No.

www.ncbi.nlm.nih.gov/pmc/articles/PMC4447773

Dec 24, 2014 ... 3%, P = 0.01), and NCP (9 vs. ... of high blood pressure or treatment with antihypertensive medications. ... All uninterpretable segments were scored with the same stenosis ... performed using STATA (Version 11, StataCorp LP, College Station, ..... Benito B, Tizon-Marcos H, Flores J, Tanguay JF, Ly H, et al.

pdfs.semanticscholar.org/0162/ab15b189050144b7e2d0531d519e2586196c.pdf

Mar 30, 2011 ... AstraZeneca Pharmaceuticals, Wilmington, DE, USA. Christie Ballantyne .... 1120 Statins and plaque progression Nicholls et al. www.cmrojournal.com ! ... two groups (66mg/dL vs. 70mg/dL with ..... P.L. has disclosed that he is an unpaid consultant or involved in .... Taylor AJ, Villines TC, Stanek EJ, et al.

www.ncbi.nlm.nih.gov/pmc/articles/PMC5518701

Aug 1, 2018 ... Find articles by Todd C. Villines .... All CAD risk factors were prospectively ascertained prior to the ... high blood pressure or treatment with blood pressure medications. ... using STATA (Version 11.2, StataCorp LP, College Station, Texas , USA) for Windows. ..... Rana JS, Dunning A, Achenbach S, et al.